We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

68 hedge funds and large institutions have $78.6M invested in BioSpecifics Technologies Corp. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

47% more capital invested

Capital invested by funds: $53.6M → $78.6M (+$25M)

10% more funds holding

Funds holding: 6268 (+6)

Holders
68
Holders Change
+6
Holders Change %
+9.68%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
27
Reduced
16
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
51
First Manhattan
New York
$101K -$688K -23,420 -89%
NFA
52
Nationwide Fund Advisors
Ohio
$96K +$2.23K +76 +3%
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$95K -$30.9K -1,052 -28%
AIG
54
American International Group
New York
$83.9K -$29 -1 -0%
US Bancorp
55
US Bancorp
Minnesota
$63K
SGAM
56
Smith Group Asset Management
Texas
$53K
PCM
57
Prelude Capital Management
New York
$39K +$32.3K +1,100 New
Bank of America
58
Bank of America
North Carolina
$32K +$26.4K +900 New
Barclays
59
Barclays
United Kingdom
$27K +$20.8K +708 +885%
FANJ
60
Financial Architects (New Jersey)
New Jersey
$25K +$25K +850 New
MA
61
MUFG Americas
New York
$16K +$13.5K +460 New
AllianceBernstein
62
AllianceBernstein
Tennessee
$14K -$11.7K -400 -50%
Federated Hermes
63
Federated Hermes
Pennsylvania
$11K -$2.79K -95 -24%
Citigroup
64
Citigroup
New York
$5K +$2.11K +72 +129%
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$4.38K +$3.64K +124 New
TRCT
66
Tower Research Capital (TRC)
New York
$2K -$74.6K -2,541 -98%
Deutsche Bank
67
Deutsche Bank
Germany
$1K -$5.87K -200 -85%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$41 +$26.7K +909 +348%
COPPSERS
69
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$1.01M -37,465 Closed
PAM
70
Paradigm Asset Management
New York
-$501K -18,600 Closed
Jane Street
71
Jane Street
New York
-$446K -16,555 Closed
Millennium Management
72
Millennium Management
New York
-$277K -10,265 Closed
SG Americas Securities
73
SG Americas Securities
New York
-$143K -5,304 Closed
PA
74
Perceptive Advisors
New York
-$100K -3,700 Closed
U
75
UBS
Switzerland
-$22K -825 Closed

BSTC Hedge Fund Activity: Q3 2014 in Review

68 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2014, worth a combined $78.6M — up 47% from $53.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 10 closed out — a net gain of 6 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.63M. The largest seller was Commonwealth of Pennsylvania Public School Employees Retirement System, exiting entirely with an estimated $1.01M sold.

  • 68 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2014, up from 62 in Q2 2014.
  • Funds reported $78.6M of BioSpecifics Technologies Corp. stock for Q3 2014, up 47% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q3 2014 and 10 closed out, a net change of +6 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2014 was EAM Investors, an estimated $1.63M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2014 was Commonwealth of Pennsylvania Public School Employees Retirement System, an estimated $1.01M sold.

Based on aggregated 13F filings for Q3 2014.